IMPROVEMENT OF INFLAMMATORY BIOMARKERS, LIVER FIBROSIS AND CLINICAL PARAMETERS WITH 3 MONTHS ZINC SULFATE FOR ALCOHOLIC CIRRHOSIS-ZAC CLINICAL TRIAL

被引:0
|
作者
Mohammad, M. K. [1 ]
Song, M. [1 ]
Falkner, K. C. [1 ]
McClain, C. J. [1 ]
Cave, M. [1 ]
机构
[1] Univ Louisville, Dept Med, Robley Rex VAMC, Louisville, KY 40292 USA
关键词
D O I
暂无
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
914
引用
收藏
页码:239A / 239A
页数:1
相关论文
共 50 条
  • [21] Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial
    Kharaziha, Pedram
    Hellstrom, Per M.
    Noorinayer, Babak
    Farzaneh, Farivar
    Aghajani, Katayoun
    Jafari, Fereshteh
    Telkabadi, Mohammad
    Atashi, Amir
    Honardoost, Maryam
    Zali, Mohammad Reza
    Soleimani, Masoud
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2009, 21 (10) : 1199 - 1205
  • [22] Nigella sativa and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: Results from a randomized, double-blind, placebo-controlled, clinical trial
    Darand, Mina
    Darabi, Zahra
    Yari, Zahra
    Saadati, Saeedeh
    Hedayati, Mehdi
    Khoncheh, Ahmad
    Hosseini-Ahangar, Behnam
    Alavian, Seyed Moayyed
    Hekmatdoost, Azita
    COMPLEMENTARY THERAPIES IN MEDICINE, 2019, 44 : 204 - 209
  • [23] The effects of zinc supplementation on inflammatory parameters in pregnant women with impaired glucose tolerance: a randomized placebo controlled clinical trial
    Roshanravan, Neda
    Tarighat-Esfanjani, Ali
    Alamdari, Naimeh Mesri
    Kheirouri, Sorayya
    Mousavi, Reihaneh
    Alizadeh, Mohammad
    PROGRESS IN NUTRITION, 2018, 20 : 330 - 336
  • [24] (+)-CYANIDANOL-3 FOR ALCOHOLIC LIVER-DISEASE - RESULTS OF A 6-MONTH CLINICAL-TRIAL
    WORLD, MJ
    APS, EJ
    SHAW, GK
    THOMSON, AD
    ALCOHOL AND ALCOHOLISM, 1984, 19 (01): : 23 - 29
  • [25] PALMITOYL-CATECHIN FOR ALCOHOLIC LIVER-DISEASE - RESULTS OF A 3-MONTH CLINICAL-TRIAL
    WORLD, MJ
    RYLE, PR
    APS, EJ
    SHAW, GK
    THOMSON, AD
    ALCOHOL AND ALCOHOLISM, 1987, 22 (04): : 331 - 340
  • [26] Curcumin nanomicelle improves semen parameters, oxidative stress, inflammatory biomarkers, and reproductive hormones in infertile men: A randomized clinical trial
    Alizadeh, Fatemeh
    Javadi, Maryam
    Karami, Ali Akbar
    Gholaminejad, Fereshteh
    Kavianpour, Maria
    Haghighian, Hossein Khadem
    PHYTOTHERAPY RESEARCH, 2018, 32 (03) : 514 - 521
  • [27] Effects of Portulaca oleracea (purslane) on liver function tests, metabolic profile, oxidative stress and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: a randomized, double-blind clinical trial
    Milkarizi, Narges
    Barghchi, Hanieh
    Belyani, Saba
    Bahari, Hossein
    Rajabzade, Farnood
    Ostad, Andisheh Norouzian
    Goshayeshi, Ladan
    Nematy, Mohsen
    Askari, Vahid Reza
    FRONTIERS IN NUTRITION, 2024, 11
  • [28] Effects of Oral Vitamin C Supplementation on Liver Health and Associated Parameters in Patients With Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial
    He, Zhangya
    Li, Xiaomin
    Yang, Hexiang
    Wu, Pei
    Wang, Shanshan
    Cao, Dan
    Guo, Xiaoxiao
    Xu, Zhangrui
    Gao, Jiayi
    Zhang, Wanyu
    Luo, Xiaoqin
    FRONTIERS IN NUTRITION, 2021, 8
  • [29] Pro-C3 in combination with clinical parameters is associated with severity of histological features of non-alcoholic steatohepatitis and fibrosis
    Leeming, Diana J.
    Nielsen, Mette J.
    Goodman, Zachary D.
    Friedman, Scott L.
    Lefebvre, Eric
    Seyedka-Zemi, Star
    Wiens, Brian
    Fischer, Laurent
    Karsdal, Morten A.
    Sanyal, Arun J.
    Ratziu, Vlad
    HEPATOLOGY, 2017, 66 : 1107A - 1108A
  • [30] Serum Pro-C3 combined with clinical parameters is superior to established serological fibrosis tests at identifying patients with advanced fibrosis among patients with non-alcoholic fatty liver disease
    Daniels, S. J.
    Nielsen, M. J.
    Krag, A.
    Eslam, M.
    Karsdal, M. A.
    Leeming, D. J.
    George, J.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S671 - S671